Table 5 Recurrent patterns and prognoses of patients stratified by preoperative serum CA19-9 level and tumor diameter
From: Preoperative predictors for early recurrence of resectable pancreatic cancer
Group | Number | CA19-9 ≥ 529 | Tumor size ≥25 mm | Recurrence (n = 60) | Distant metastasis (n = 32) | Local recurrence (n = 28) | Median OS (months) | P value* |
|---|---|---|---|---|---|---|---|---|
1 | 5 | + | − | 5 (100%) | 4 (80.0%) | 1 (20%) | 12 |  |
2 | 32 | − | − | 16 (50%) | 7 (21.9%) | 9 (28.1%) | Over 102.9 | 0.0002 |
3 | 20 | + | + | 16 (80%) | 11 (55%) | 5 (25%) | 27 | 0.0485 |
4 | 33 | − | + | 23 (69.7%) | 10 (30.3%) | 13 (39.4%) | 45.3 | 0.028 |